Similarly, we also observed elevated levels of dsRNA and IFNB1 expression in AML cells treated with GSK–LSD1 alone or in combination with LY2090314 (Extended Data Fig. 3k,m). The gene discussed is KDM1A; the disease is acute myeloid leukemia.